Skip to content
Lower risk Medical device recall · FDA · Published January 17, 2020

Covidien Endo GIA Ultra Stapler Recall: Infection Risk from Sterile Barrier Compromise

Covidien recalls 12mm Endo GIA Ultra Universal Staplers for potential infection risk if sterile barrier is compromised. Affected items have specific item codes and lot numbers.

🇺🇸 FDA recall #Z-1264-2020Medical deviceCovidien ›
Take action

Contact the company

Recalling firmCOVIDIEN LLC15 Hampshire St · Mansfield, MA 02048-1113
✎ GovInfoNow plain-language explainer

Covidien is recalling its Endo GIA Ultra Universal Staplers (12mm) used in general surgery because the sterile barrier might be compromised, increasing infection risk. This affects surgeons and surgical teams who use these devices during procedures. Read more at govinfonow.com/recall/65980-covidien-endo-gia-ultra-stapler-recall-infection-risk-from-sterile.

Source Summary by GovInfoNow · govinfonow.com/recall/65980-covidien-endo-gia-ultra-stapler-recall-infection-risk-from-sterile · Updated August 19, 2026 · FDA enforcement record: FDA #Z-1264-2020

Cite this page

“Covidien Endo GIA Ultra Stapler Recall: Infection Risk from Sterile Barrier Compromise.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/65980-covidien-endo-gia-ultra-stapler-recall-infection-risk-from-sterile. Based on FDA recall #Z-1264-2020 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1264-2020%22&limit=1).

The FDA announced on Jan. 17, 2020, that Covidien LLC voluntarily recalled the Covidien Endo GIA Ultra Universal Stapler 12 mm due to a potential compromise of the sterile barrier. This defect may increase the risk of infection for patients. The recall affects 2,180 units distributed in the U.S., Israel, and Japan.

How to tell if you have it

  • Brand: Covidien
  • Product: Covidien Endo GIA Ultra Universal Stapler 12 mm
  • Item Code: EGIAUSTND
  • Lot Number: P9E0022Y

The hazard

The recall addresses the potential for the sterile barrier to be compromised. According to the FDA, products with a compromised sterile barrier may result in a potentially increased risk for infection.

Context

GovInfoNow's records show Covidien LLC has 52 other recalls on record since Aug. 7, 2017. Other recent recalls of similar products include the Covidien EndoFLIP System recall (May 13, 2026), the Covidien Mon-a-Therm Stethoscope Recall (April 23, 2026), and the Covidien Shiley Disposable Decannulation Plug Recall (April 23, 2026). Additional similar recalls include the Covidien EndoStitch Polysorb Loading Unit Recall (April 15, 2026), the Covidien Surgipro II S8698GX recall (June 24, 2026), and the Covidien V-Loc 90 Wound Closure Device Recall (June 24, 2026).

How to tell if you have this one

Check for the item code EGIAUSTND and lot number P9E0:0022Y on the product. These devices are intended for resection and transection in general surgery procedures.

  • Brand
    Covidien
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Look for item code EGIAUSTND and lot number P9E0022Y on the device.

Where it went and when

Where it was distributed

Distributed nationwide, and outside the U.S.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “US Nationwide, Israel, and Japan” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide, and outside the U.S.

Recall timeline

FDA terminated this recall 2.5 years after the firm started it.

1. Firm started the recall: Jan 17, 202012. FDA classified it Class II: Feb 18, 202023. Published in FDA’s Enforcement Report: Feb 26, 202034. FDA terminated the recall: Jul 29, 2022420202022
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

Is this a safety hazard that requires immediate action?

No immediate action is needed. The recall is for potential infection risk if the sterile barrier is compromised, which requires checking product details.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-1264-2020 (January 17, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-1264-2020 to see it in context.
  • Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA